THE COMPANY

Who are we?


Welcome to INNITIUS, where innovation meets women's health. Our dedicated team specializes in crafting cutting-edge diagnostics that empower women to take control of their well-being. Through meticulous research and development, we create advanced medical devices tailored to detect pathologies manifested by shifts in human tissue's mechanical properties, notably the shear modulus.

Our driving force is a profound passion for addressing critical clinical gaps and enhancing healthcare accessibility. We prioritize serving underserved communities and tackling inefficiencies within the healthcare system. By harnessing the power of Artificial Intelligence (AI) in conjunction with Torsional Waves Elastography (TWE), we are revolutionizing healthcare information. Our vision is to transform this data into a valuable tool that spearheads transformative shifts in clinical protocols, paving the way for a brighter future in women's healthcare.

Join us on this transformative journey as we bridge the gap between innovative technology and women's well-being.

OUR MISSION

Our mission is to create breakthrough medical devices that can enhance patient care, leveraging technologies that provide a new dimension.


Leveraging AI, we believe that healthcare information can be transformed, through careful analysis, into a useful tool to improve our products, but with a larger societal impact: To arrive at a better understanding of diseases and to lead change in clinical protocols.

OUR VISION

To become leader in the medical diagnostics industry, serving as a more accurate complementary tool to existing devices to improve the standard of care.


We hope to improve maternal and neonatal mortality and morbidity while minimizing the healthcare burden. INNITIUS aims to have the largest database of cervical consistency of women in Europe, paving the way for novel research and improved clinical care.

OUR VALUES

Our Code of Conduct has been designed to enforce the right culture and perform operations that are based on our values

Societal Impact

Creating technology and knowledge with a social purpose, bringing real value to the healthcare environment and their patients by providing true and consistent welfare globally and improving access to quality healthcare.

Quality of Results

ensured by reliability and repeatability, providing customer security. Plan, perform, prove & act.

Contribute to Local Ecosystems

generate knowledge and trained people in the medical device sector locally, leading to a region with a high diversity of companies and start-ups developing medical devices in the future.

Foster Talent

by encouraging our team to grow personally and professionally, integrating a growth mindset, and forming tight relationships based on our values and culture to support each other

OUR PEOPLE

Meet the INNITIUS team

rubenmolinabrm02
fm01fm02
mt01mt02
mc01mc02
ag01ag02
ip01ip02
ig01ig02
pd01pd02
mm01mm02
am01am02
jb01jb02
ca01ca02
adm01adm02b
ed01ed02b

Advisors

Golo von Basum
R&D & Innovation Advisor
Marta Walker
RA/QA Advisor
Rajat Mukherjee
ML & Clinical Trial Statistical Design Advisor
OUR HISTORY

INNITIUS is a medical device startup based in Spain, born in 2018 as a spinoff of the University of Granada and the Andalusian Health Service.


Although the company is currently based in Bilbao, it was established as a result of multiple research projects that originated from the collaboration of both Andalusian public entities.

In 2009, Dr. Engineer Rus (University of Granada) embarked on extensive research on how to apply the knowledge developed in the field of civil engineering to quantify the mechanical properties of materials in the field of tissues. The objective was to address diagnostic problems with a high impact on society from a completely disruptive perspective. Dr. Rus created the Ultrasonics Lab at that time and later joined forces with the Electronics Sensors research group, led by Miguel Angel Carvajal, also from the University of Granada.

In 2012, after an event to exchange researchers and projects between the University of Granada and the Andalusian Health Service, Dr. Jesús Florido (sadly deceased) and Dr. Francisca Molina (Andalusian Health Service) identified the potential of the new technique being developed by the University of Granada for the diagnosis of preterm labor. This is how the Torsional Wave Elastography technique was born.

After several years of collaborative development and multiple prototypes, the decision was made to create a spinoff. At that time, Rubén Molina (currently the CEO of INNITIUS), who was on a pre-doctoral contract at the University of Granada, decided to leave the research and, two years later (December 2017/January 2018), create INNITIUS.

In 2020, INNITIUS moved to Bilbao, where its current headquarters are located. After more than 10 years of development, the product that originated from an idea in 2009 is taking the final steps to reach the market.

Investors & Supporters

PRODUCT

LifeCycle

  • Q2 2021Device Prototype

  • Q2 2024CT1: Algorithm Development

  • Q2 2024Market Product Development (HW + SW)

  • Q3 2024Transfer to Production

  • Q1 2025CT2: Algorithm + Solution Value

  • Q1 2025CT2: Technical File Development

  • Q3 2025CE Marking

CURRENT

Clinical Settings where INNITIUS
is conducting clinical research.

Hospital Universitario San Cecilio, Granada (Granada)

Hospital Universitario de Torrejón de Ardoz, Torrejón (Madrid)

Hospital Universitario de Cruces, Barakaldo (Bizkaia)

Hospital Universitario de Basurto, Bilbao (Bizkaia)

Hospital Universitario Virgen de Arixaca,  Murcia (Murcia)

Hospital San José, Madrid (Madrid)

Hospital Universitario Dexeus, Barcelona (Barcelona)

Hospital Clinic, Barcelona (Barcelona)

Hospital San Joan de Deu, Barcelona (Barcelona)

Hospital Vall d’Hebron,  Barcelona (Barcelona)